<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under
Section 12(g) of the Securities Exchange Act of 1934 or
Suspension of Duty to file Reports Under Sections 13
and 15(d) of the Securities Exchange Act of 1934.
Commission File Number 000-28016
BIOPSYS MEDICAL, INC.
_______________________________________________________________________________
(Exact name of registrant as specified in its charter)
3 MORGAN, IRVINE, CALIFORNIA 92618, (714) 460-7815
_______________________________________________________________________________
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
COMMON STOCK, $.001 PAR VALUE
________________________________________________________________________________
(Title of each class of securities covered by this Form)
NONE
________________________________________________________________________________
(Titles of all other classes of securities for which a duty to file reports
under Section 13(a) or 15(d) remains)
Please place an X in the box(es) or designate the appropriate rule
provision(s) relied upon the terminate or suspend duty by file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [X]
Approximate number of holders of record as of the certification or notice date:
ONE(1)
Pursuant to the requirements of the Securities Exchange Act of 1934,
Maxis, Inc. has caused this certification/notice to be signed on its behalf by
the undersigned duly authorized person.
Date: July 31, 1997 By: /s/ J. CASEY MCGLYNN
- ------------------- ---------------------
Name: J. Casey McGlynn
Title: Secretary
